Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations

Published:2015-10-21 Issue:11 Volume:90 Page:992-997
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Xu Yang¹²³,Sun Yanjun¹,Shen Hongjie¹,Ding Lin⁴,Yang Zhen¹,Qiu Huiying¹²,Sun Aining¹²³,Chen Suning¹²,Wu Depei¹²³

Affiliation:

1. Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health; The First Affiliated Hospital of Soochow University; Suzhou People's Republic of China

2. Collaborative Innovation Center of Hematology; Soochow University; Suzhou People's Republic of China

3. Suzhou Institute of Blood and Marrow Transplantation, Soochow University; Suzhou People's Republic of China

4. Department of Pathology; University of Michigan Medical School; Ann Arbor Michigan

Funder

Jiangsu Provincial Special Program of Medical Science

Jiangsu Provincial Key Medical Center

Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)

National Natural Science Foundation of China

Specialized Research Fund for the Doctoral Program of Higher Education of China

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24135/fullpdf

Reference30 articles.

1. Acute myeloid leukaemia;Estey;Lancet,2006

2. Gene mutation and AML pathogenesis;Dombret;Blood,2011

3. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis;Thiede;Blood,2002

4. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: Further evidence for CEBPA double mutant AML as a distinctive disease entity;Taskesen;Blood,2011

5. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations;Döhner;Blood,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of allogeneic stem cell transplantation in acute myeloid leukemia patients with epigenetic modifier gene mutations;2024-01-11

2. Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission;Leukemia & Lymphoma;2023-11-22

3. A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation;Bone Marrow Transplantation;2023-04-18

4. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies;Signal Transduction and Targeted Therapy;2023-02-17

5. DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway;Cell Communication and Signaling;2022-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3